2025-10-11 - Analysis Report
Okay, here's an analysis of Salesforce (CRM) based on the information you provided, formatted with numbers, key points, and brief analysis.

## Salesforce Inc. (CRM) Analysis

**Company Overview:** Salesforce, Inc. is a global leader in cloud-based software, providing customer relationship management (CRM) solutions.

### 1. Performance vs. S&P 500 (VOO)

*   **CRM Cumulative Return:** -10.95%
*   **VOO Cumulative Return:** 99.08%
*   **Spread:**
    *   Current: -111.0
    *   Max: 54.1
    *   Min: -111.4
    *   Relative Spread: 0.2
*   **Analysis:** CRM has significantly underperformed the S&P 500. The cumulative return difference is substantial (-111.0%). The relative spread of 0.2 indicates that CRM's underperformance is near the lowest end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 39.0% | 70.6% | 10.0% | -0.0 | 97.4 |
| 2016-2018  | 34.0% | 73.5% | 19.0% | 0.1 | 130.5 |
| 2017-2019  | 22.0% | 73.5% | 0.0% | 0.4 | 154.9 |
| 2018-2020  | 14.0% | 73.5% | -10.0% | 0.4 | 212.0 |
| 2019-2021  | 37.0% | 71.9% | -10.0% | 0.7 | 242.1 |
| 2020-2022  | -78.0% | 74.7% | -78.0% | 0.4 | 126.3 |
| 2021-2023  | -47.0% | 76.6% | -49.0% | -0.6 | 250.7 |
| 2022-2024  | -42.0% | 76.6% | -63.0% | -0.4 | 318.5 |
| 2023-2025  | 0.0% | 76.6% | -63.0% | -2.0 | 230.2 |

*   **Analysis:**
    *   **CAGR:** Fluctuating CAGR, with recent periods showing negative growth.
    *   **MDD:** High Maximum Drawdown (MDD) indicates significant volatility and risk.
    *   **Alpha:**  Recent Alpha is negative, implying underperformance relative to its benchmark.
    *   **Beta:** Beta values fluctuate, suggesting varying sensitivity to market movements. The recent Beta of -2.0 suggests an inverse relationship with the market.
    *   **Cap(B):** Market capitalization has fluctuated, reflecting changes in investor sentiment and stock performance.

### 2. Recent Price Action

*   **Current Price:** 241.67
*   **Last Market Data:** Price: 241.70, Previous Close: 245.33, Change: -1.48
*   **5-day Moving Average:** 241.60
*   **20-day Moving Average:** 242.04
*   **60-day Moving Average:** 248.21
*   **Analysis:** The price is below the 20-day and 60-day moving averages, suggesting a short-term downtrend. The recent price decrease (change: -1.48) confirms this.

### 3. Market Risk Indicators & Expected Return

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 43.31
*   **PPO:** 0.10
*   **Hybrid Signal:**  cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Spread Change:** 0.2 (+) - Short-term increase
*   **Expected Return:** -4624.9%
*   **Analysis:**
    *   MRI indicates high investment recommendation, but this seems contradictory given other indicators.
    *   RSI is below 50, suggesting potential for further downside.
    *   PPO is slightly positive, indicating a minor uptrend in momentum.
    *   Hybrid Signal suggests a "Buy" recommendation based on the MRI, but this should be viewed with caution.
    *   The recent increase in the relative spread indicates a short-term improvement in performance compared to the S&P 500.
    *   The extremely negative expected return is a significant red flag and warrants further investigation.

### 4. Recent News & Significant Events

*   **Key Headlines:**
    *   Salesforce Pounced Early On AI. Why Is Its Stock Slumping?
    *   Analyst on Oracle (ORCL): ‘Co-CEO Roles Don’t Really Work’ (Potential competitive implications)
    *   Oakmark Equity and Income Fund Established a Position in Salesforce (CRM) in Q3
    *   Salesforce Stock Trades Near 52-Week Low: Time to Buy, Sell or Hold?
    *   AI Sales Development Representative (SDR) Global Research Report 2025-2030: $15 Billion Market (Potential growth area for Salesforce)
*   **Analysis:** The news is mixed.  While there's positive news regarding institutional investment and the potential of the AI SDR market, the headline about the stock slumping despite early AI adoption is concerning. The Oracle article could impact sector sentiment.

### 4-2) Analyst Opinions

*   **Consensus:**
    *   Key: Buy
    *   Mean: 1.60 (~Buy)
    *   Opinions: 51
    *   Target Price (avg/high/low): 334.38 / 430.00 / 221.00
*   **Analysis:** The analyst consensus is "Buy" with a significant upside potential based on the average target price. However, the low target price (221.00) is below the current price, suggesting some analysts are bearish.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출     |
|--------------|------|----------|
| 2025-09-04   | 1.97 | 10.24 B$ |
| 2025-05-29   | 1.61 | 9.83 B$  |
| 2024-12-04   | 1.6  | 9.44 B$  |
| 2024-08-29   | 1.48 | 9.32 B$  |
| 2025-09-04   | 1.48 | 9.32 B$  |

*   **Analysis:** Both EPS and Revenue have shown positive trends in recent quarters.  The latest quarter shows strong EPS and revenue figures.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-07-31   | $10.24B   | 78.10%        |
| 2025-04-30   | $9.83B    | 76.96%        |
| 2025-01-31   | $9.99B    | 77.81%        |
| 2024-10-31   | $9.44B    | 77.71%        |
| 2024-07-31   | $9.32B    | 76.85%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-07-31   | $61.33B   | 3.08% |
| 2025-04-30   | $60.67B   | 2.54% |
| 2025-01-31   | $61.17B   | 2.79% |
| 2024-10-31   | $58.52B   | 2.61% |
| 2024-07-31   | $57.63B   | 2.48% |

*   **Analysis:**
    *   Revenue is consistently growing, demonstrating business expansion.
    *   Profit Margins are very high and relatively stable, indicating strong operational efficiency.
    *   Equity is increasing, suggesting healthy capital management.
    *   ROE is positive and showing a slight uptrend, indicating improving profitability relative to equity.

### 7. Overall Assessment

**Summary:**  Salesforce (CRM) presents a mixed picture. While recent earnings and financial data show positive trends in revenue, profitability, and equity, the stock has significantly underperformed the S&P 500. Recent price action suggests a short-term downtrend, and the negative expected return is a major concern. Analyst consensus remains "Buy," but the significant spread in target prices indicates uncertainty. The news highlights potential growth areas like AI but also raises concerns about the stock's performance despite these efforts.

**Recommendation:**  Given the conflicting signals, a cautious approach is warranted. While the fundamental financials look sound, the underperformance relative to the market and the negative expected return are red flags. Further research is needed to understand the reasons behind the underperformance and the validity of the expected return figure.
